Tapewire

NYSE · USD

ICE

Intercontinental Exchange, Inc.

Export transactions ↓
Tapewire entity
1809
SEC CIK
0001571949
Parsed reports
941

Last 12 months

Inside the activity.

0 purchase rows · 64 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202505
Jan 202600
Feb 2026026
Mar 202601
Apr 202600
May 202606
Jun 202602
Jul 202604
Aug 2026010
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 10, 2023 Filed Feb 14, 2023 22:56 UTC
Williams Stuart GlenChief Operating Officer
GrantCommon Stock 1,554 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009319 · doc4.xml · nonDerivative · entry 1

Williams Stuart Glen · CIK 0001942706 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,465

F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:49 UTC
Surdykowski Andrew JGeneral Counsel
Tax withholdingCommon Stock 885 $108.71 $96,208.35
Disclosure

SEC source: 0001209191-23-009314 · doc4.xml · nonDerivative · entry 2

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,288

F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 35,905 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:49 UTC
Surdykowski Andrew JGeneral Counsel
GrantCommon Stock 2,590 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009314 · doc4.xml · nonDerivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,173

F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500.

F2 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:46 UTC
Kapani MayurChief Technology Officer
Tax withholdingCommon Stock 1,756 $108.71 $190,894.76
Disclosure

SEC source: 0001209191-23-009310 · doc4.xml · nonDerivative · entry 2

Kapani Mayur · CIK 0001917418 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,832

F4 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations.

F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 42,665 shares of common stock and 9,167 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:46 UTC
Kapani MayurChief Technology Officer
GrantCommon Stock 3,886 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009310 · doc4.xml · nonDerivative · entry 1

Kapani Mayur · CIK 0001917418 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,588

F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500.

F2 · balance_after: Amount of securities beneficially owned includes 120 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

F3 · balance_after: Amount of securities beneficially owned includes 93 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:44 UTC
Martin Lynn CPresident, NYSE Group
Tax withholdingCommon Stock 2,645 $108.71 $287,537.95
Disclosure

SEC source: 0001209191-23-009308 · doc4.xml · nonDerivative · entry 2

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,523

F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 32,378 shares of common stock and 2,560 unvested restricted stock units ("RSUs"), and 13,585 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:44 UTC
Martin Lynn CPresident, NYSE Group
GrantCommon Stock 5,181 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009308 · doc4.xml · nonDerivative · entry 1

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,168

F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500.

F2 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:42 UTC
Foley DouglasSVP, HR & Administration
Tax withholdingCommon Stock 470 $108.71 $51,093.70
Disclosure

SEC source: 0001209191-23-009306 · doc4.xml · nonDerivative · entry 2

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,094

F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,264 shares of common stock and 3,830 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:42 UTC
Foley DouglasSVP, HR & Administration
GrantCommon Stock 1,554 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009306 · doc4.xml · nonDerivative · entry 1

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,564

F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500.

F2 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:43 UTC Tax withholdingCommon Stock 3,227 $108.71 $350,807.17
Disclosure

SEC source: 0001209191-23-009307 · doc4.xml · nonDerivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,077

F4 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations.

F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 103,499 shares of common stock and 18,578 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:43 UTC GrantCommon Stock 7,124 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009307 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,304

F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500.

F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

F3 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:42 UTC
Edmonds Christopher ScottChief Development Officer
Tax withholdingCommon Stock 1,163 $108.71 $126,429.73
Disclosure

SEC source: 0001209191-23-009304 · doc4.xml · nonDerivative · entry 2

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,754

F4 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations.

F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,427 shares of common stock and 3,944 unvested restricted stock units ("RSUs"), and 6,383 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:42 UTC
Edmonds Christopher ScottChief Development Officer
GrantCommon Stock 2,590 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009304 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,917

F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 7, 2020. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2022 and was based on the total shareholder return from January 1, 2020 through December 31, 2022 relative to the S&P 500.

F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

F3 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022.

Read SEC document
February 07, 2023 Filed Feb 9, 2023 21:34 UTC
Gardiner WarrenChief Financial Officer
Tax withholdingCommon Stock 137 $109.35 $14,980.95
Disclosure

SEC source: 0001209191-23-008022 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,482

F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, the remaining 450 shares were issued on February 7, 2023, of which 137 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 7,831 shares of common stock and 1,561 unvested restricted stock units ("RSUs"), and 6,090 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 07, 2023 Filed Feb 9, 2023 16:36 UTC
Namkung James WChief Accounting Officer
Tax withholdingCommon Stock 136 $109.35 $14,871.60
Disclosure

SEC source: 0001209191-23-008027 · doc4.xml · nonDerivative · entry 1

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,258

F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, the remaining 450 shares were issued on February 7, 2023, of which 136 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 13,420 shares of common stock and 438 unvested restricted stock units ("RSUs"), and 5,400 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 06, 2023 Filed Feb 8, 2023 21:59 UTC
Gardiner WarrenChief Financial Officer
Tax withholdingCommon Stock 134 $108.32 $14,514.88
Disclosure

SEC source: 0001209191-23-007835 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,619

F1 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 438 shares were issued on February 6, 2023, of which 134 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 438 shares are scheduled to be issued on February 5, 2024 and taxes for this issuance will be withheld and reported at the time of vesting.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 7,518 shares of common stock and 2,011 unvested restricted stock units ("RSUs"), and 6,090 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 06, 2023 Filed Feb 8, 2023 17:00 UTC
Namkung James WChief Accounting Officer
Tax withholdingCommon Stock 132 $108.32 $14,298.24
Disclosure

SEC source: 0001209191-23-007841 · doc4.xml · nonDerivative · entry 1

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,394

F1 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 438 shares were issued on February 6, 2023, of which 132 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 438 shares are scheduled to be issued on February 5, 2024 and taxes for this issuance will be withheld and reported at the time of vesting.

F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

F3 · balance_after: Amount of securities beneficially owned includes 76 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 30, 2022.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 13,106 shares of common stock and 888 unvested restricted stock units ("RSUs"), and 5,400 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:37 UTC
Gardiner WarrenChief Financial Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 12,780 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007527 · doc4.xml · derivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,780

Underlying: Common Stock · 12,780 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 16:41 UTC
Namkung James WChief Accounting Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 4,381 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007537 · doc4.xml · derivative · entry 1

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,381

Underlying: Common Stock · 4,381 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 16:42 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 108,633 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007542 · doc4.xml · derivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,633

Underlying: Common Stock · 108,633 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:44 UTC
Williams Stuart GlenChief Operating Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 10,954 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007549 · doc4.xml · derivative · entry 1

Williams Stuart Glen · CIK 0001942706 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,954

Underlying: Common Stock · 10,954 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:43 UTC
Surdykowski Andrew JGeneral Counsel
GrantEmployee Stock Option (right to buy) Holding · Derivative 10,954 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007545 · doc4.xml · derivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,954

Underlying: Common Stock · 10,954 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:40 UTC
Martin Lynn CPresident, NYSE Group
GrantEmployee Stock Option (right to buy) Holding · Derivative 20,083 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007533 · doc4.xml · derivative · entry 1

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,083

Underlying: Common Stock · 20,083 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:40 UTC
Kapani MayurChief Technology Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 14,606 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007531 · doc4.xml · derivative · entry 1

Kapani Mayur · CIK 0001917418 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,606

Underlying: Common Stock · 14,606 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:38 UTC GrantEmployee Stock Option (right to buy) Holding · Derivative 32,863 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007530 · doc4.xml · derivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,863

Underlying: Common Stock · 32,863 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:35 UTC
Foley DouglasSVP, HR & Administration
GrantEmployee Stock Option (right to buy) Holding · Derivative 5,477 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007525 · doc4.xml · derivative · entry 1

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,477

Underlying: Common Stock · 5,477 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:35 UTC
Edmonds Christopher ScottChief Development Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 16,431 $0.00 Strike: $107.66 $0.00
Disclosure

SEC source: 0001209191-23-007523 · doc4.xml · derivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,431

Underlying: Common Stock · 16,431 shares

Expires 2033-02-03

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 3, 2024, 33.33% of the options vest on February 3, 2025 and 33.33% of the options vest on February 3, 2026.

Read SEC document
December 08, 2022 Filed Dec 9, 2022 17:37 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
GiftCommon Stock 67,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-060564 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,188,207

F1 · shares: This transaction involved a gift of 67,000 shares of the Issuer's common stock by the reporting person to a philanthropic organization.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,128,363 shares of common stock and 59,844 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
December 05, 2022 Filed Dec 7, 2022 23:42 UTC
Martin Lynn CPresident, NYSE Group
Tax withholdingCommon Stock 654 $107.09 $70,036.86
Disclosure

SEC source: 0001209191-22-060251 · doc4.xml · nonDerivative · entry 1

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,911

F1 · shares: Represents shares of restricted stock issued to the filing person on December 3, 2021. The restricted stock units vest over three years (1/3 on December 3, 2022, 1/3 on December 3, 2023 and 1/3 on December 3, 2024). Of the 3,840 shares, 1,280 shares were issued on December 5, 2022, of which 654 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,560 shares are scheduled to be issued on December 3, 2023 and December 3, 2024 and taxes for these issuances will be withheld and reported at the time of vesting.

F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 29,766 shares of common stock and 2,560 unvested restricted stock units ("RSUs"), and 13,585 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
November 29, 2022 Filed Nov 30, 2022 20:45 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 4,143 $106.00 $439,159.66
Disclosure

SEC source: 0001209191-22-059127 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 2,971,705

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $105.80 - $106.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The reporting person indirectly owns 2,971,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

Read SEC document
November 29, 2022 Filed Nov 30, 2022 20:45 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 25,857 $105.27 $2,722,041.38
Disclosure

SEC source: 0001209191-22-059127 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 2,975,848

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $104.80 - $105.79. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
November 23, 2022 Filed Nov 28, 2022 22:38 UTC
Foley DouglasSVP, HR & Administration
SaleCommon Stock 1,600 $105.98 $169,568.00
Disclosure

SEC source: 0001209191-22-058886 · doc4.xml · nonDerivative · entry 1

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,934

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 17,104 shares of common stock and 3,830 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
November 14, 2022 Filed Nov 15, 2022 22:50 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 1,000 $0.00 Strike: $41.59 $0.00
Disclosure

SEC source: 0001209191-22-057118 · doc4.xml · derivative · entry 3

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Underlying: Common Stock · 1,000 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

Read SEC document
November 14, 2022 Filed Nov 15, 2022 22:50 UTC
Surdykowski Andrew JGeneral Counsel
SaleCommon Stock 2,500 $105.00 $262,500.00
Disclosure

SEC source: 0001209191-22-057118 · doc4.xml · nonDerivative · entry 2

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,507

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 34,124 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
November 14, 2022 Filed Nov 15, 2022 22:50 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionCommon Stock 1,000 $41.59 $41,590.00
Disclosure

SEC source: 0001209191-22-057118 · doc4.xml · nonDerivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,007

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 1,492 $0.00 Strike: $67.00 $0.00
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · derivative · entry 11

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,299

Underlying: Common Stock · 1,492 shares

Expires 2028-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: These options are fully vested.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 63,680 $0.00 Strike: $41.37 $0.00
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · derivative · entry 10

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 63,680 shares

Expires 2024-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: These options are fully vested.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 1,590 $95.79 $152,299.10
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 8

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,001,705

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F9 · price: The price range for the aggregate amount sold by the direct holder is $95.65 - $95.98. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F10 · balance_after: As previously reported, the reporting person also indirectly owns 3,001,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 5,198 $95.25 $495,103.78
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 7

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,003,295

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F8 · price: The price range for the aggregate amount sold by the direct holder is $94.65 - $95.63. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 3,212 $94.07 $302,148.66
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 6

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,008,493

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F7 · price: The price range for the aggregate amount sold by the direct holder is $93.62 - $94.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 16,277 $95.74 $1,558,394.16
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 5

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,255,207

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F5 · price: The price range for the aggregate amount sold by the direct holder is $95.60 - $95.98. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F6 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,195,363 shares of common stock and 59,844 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 43,299 $95.22 $4,122,926.45
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 4

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,271,484

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F4 · price: The price range for the aggregate amount sold by the direct holder is $94.60 - $95.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 27,801 $94.06 $2,615,020.44
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 3

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,314,783

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $93.59 - $94.58. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,492 $67.00 $99,964.00
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,342,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 16:44 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 63,680 $41.37 $2,634,441.60
Disclosure

SEC source: 0001209191-22-051023 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,341,092

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:20 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 1,000 $0.00 Strike: $57.31 $0.00
Disclosure

SEC source: 0001209191-22-047994 · doc4.xml · derivative · entry 5

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,439

Underlying: Common Stock · 1,000 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:20 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 1,000 $0.00 Strike: $41.59 $0.00
Disclosure

SEC source: 0001209191-22-047994 · doc4.xml · derivative · entry 4

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 1,000 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:20 UTC
Surdykowski Andrew JGeneral Counsel
SaleCommon Stock 2,500 $107.00 $267,500.00
Disclosure

SEC source: 0001209191-22-047994 · doc4.xml · nonDerivative · entry 3

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,007

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 35,624 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:20 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionCommon Stock 1,000 $57.31 $57,310.00
Disclosure

SEC source: 0001209191-22-047994 · doc4.xml · nonDerivative · entry 2

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:20 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionCommon Stock 1,000 $41.59 $41,590.00
Disclosure

SEC source: 0001209191-22-047994 · doc4.xml · nonDerivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: Amount of securities beneficially owned includes 132 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.